Simon Kebede Merid

Simon Kebede Merid

Auto-generated profile, based on publicly available information

Simon Kebede Merid

Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet Stockholm Sweden

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2018 in Allergy
Verified
Journal Article
Open access
PDF file
NFNiloufar Farzan
Niloufar Farzan
SVSusanne J.H. Vijverberg
Susanne J.H. Vijverberg
NHNatalia Hernandez-Pacheco
Natalia Hernandez-Pacheco
EBElisabeth H D Bel
Elisabeth H D Bel
VBVojko Berce
Vojko Berce
Anke H. Maitland-van der ZeeAnke H. Maitland-van der Zee
Anke H. Maitland-van der Zee

19 August 2024 in Allergy
Verified
Journal Article
Open access
HTHelena Thulin
Helena Thulin
LMLadan Mansouri
Ladan Mansouri
MAMaria Altman
Maria Altman
SMSimon Kebede Merid
Simon Kebede Merid
JLJoachim Lundahl
Joachim Lundahl
JSJesper Säfholm
Jesper Säfholm
Background: Noninvasive biomarkers for diagnosing and monitoring eosinophilic esophagitis (EoE) are currently lacking. This study evaluates 20 biomarkers in serum and saliva, aiming to assess their diagnostic potential in pediatric EoE patients and healthy individuals.Methods: Blood and saliva from children undergoing upper endoscopy were analyzed for biomarkers, including absolute eosinophil count (AEC), eosinophil‐derived neurotoxin (EDN), total and specific IgG4‐antibodies (sIgG4), specific IgE‐antibodies (sIgE) and 15‐hydroxyeicosatetraenoic acid (15(S)‐HETE). Some patients participated twice, forming a longitudinal cohort. The ability to use the biomarkers to predict the EoE diagnosis was evaluated.Results: Analysis from 105 children divided into active EoE, remission, and healthy, revealed elevated levels of serum biomarkers (AEC, EDN, 15(S)‐HETE, sIgG4, and sIgE) in active EoE compared to healthy individuals. A combination of biomarkers (AEC, EDN, sIgE to egg white and wheat) and symptoms showed an AUC of 0.92 in distinguishing between the three groups. We further showed that optimal cutoff values for these biomarkers could discriminate between active EoE and healthy with a sensitivity of 88% and a specificity of 100% in distinguishing EoE (active and in remission) from healthy. Longitudinally, levels of EDN, sIgG4 to Bos d 4, Bos d 5, Bos d 8, gliadin, and birch, and sIgE to milk decreased in patients progressing from active EoE to remission (p <.05).Conclusions: This study identified novel biomarkers associated with EoE and proposes a panel, together with symptoms, for effective discrimination between active EoE, EoE in remission, and healthy individuals. The findings may contribute to a less invasive diagnostic method and may be a potential surveillance tool for pediatric EoE patients.

20 October 2021 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
PDF file
SBSophia Björkander
Sophia Björkander
SMSimon Kebede Merid
Simon Kebede Merid
DBDavid Brodin
David Brodin
JBJosef Brandström
Josef Brandström
FFFredrik Fagerström-Billai
Fredrik Fagerström-Billai
EMErik Melén
Erik Melén
Click on the article title to read more.

4 June 2025 in Allergy
Verified
Journal Article
Open access
NHNatalia Hernandez-Pacheco
Natalia Hernandez-Pacheco
SBSophia Björkander
Sophia Björkander
SMSimon Kebede Merid
Simon Kebede Merid
MKMaura Kere
Maura Kere
AKAshish Kumar
Ashish Kumar
EMErik Melén
Erik Melén
Background: Protein quantitative trait loci (pQTLs) remain underexplored in asthma but might provide valuable insights into the underlying molecular mechanisms. This study aimed to investigate associations between genetic variation and inflammation‐related plasma proteins and to assess differences in the levels of genetically determined proteins in subjects with signatures of type‐2 inflammation and/or asthma.Methods: A pQTL mapping of 92 inflammation‐related plasma proteins was conducted in young adults from the Swedish BAMSE cohort (n = 1538). Replication of sentinel pQTLs was attempted, and the overlap and colocalization of pQTLs with expression quantitative trait loci (eQTLs) were investigated using publicly available data. Proteins with significant pQTLs were tested for association with type‐2 signatures defined as high levels of fractional exhaled nitric oxide, blood eosinophils, and/or sensitization to airborne allergens in subjects with or without asthma in BAMSE.Results: Forty‐five sentinel pQTLs (33 cis, 12 trans) for 39 inflammation‐related proteins were identified (p ≤ 7.14 × 10−11), and a high proportion of these were validated in independent populations. A high likelihood for colocalization of cis‐pQTLs and cis‐eQTLs was observed for 19 proteins in different tissues. Six of the 39 circulating proteins with significant pQTLs were associated with type‐2 signatures and/or asthma, and matrix metalloproteinase‐10 (MMP‐10) showed the most significant associations.Conclusions: These findings underscore the existence of a genetic component influencing the plasma levels of proteins involved in inflammatory processes, including MMP‐10, which is suggested to have a role in high type‐2 inflammation in asthma subjects.

5 February 2025 in Allergy
Verified
Journal Article
Open access
EMElena Martin-Gonzalez
Elena Martin-Gonzalez
JPJavier Perez-Garcia
Javier Perez-Garcia
EHEsther Herrera-Luis
Esther Herrera-Luis
MMMario Martin‐Almeida
Mario Martin‐Almeida
SKSimon Kebede‐Merid
Simon Kebede‐Merid
Maria Pino-YanesMaria Pino-Yanes
Maria Pino-Yanes
Background: Asthma exacerbations (AEs) represent the major contributor to the global asthma burden. Although genetic and environmental factors have been associated with AEs, the role of epigenetics remains uncovered. Objective: This study aimed to identify whole blood DNA methylation (DNAm) markers associated with AEs in Europeans. Methods: DNAm was assessed in 406 blood samples from Spanish individuals using the Infinium MethylationEPIC microarray (Illumina). An epigenome‐wide association study was conducted to test the association of DNAm with AEs at differentially methylated positions, regions, and epigenetic modules. CpGs suggestively associated with AEs (false discovery rate [FDR] < 0.1) were followed up for replication in 222 European individuals, and the genome‐wide significance ( p < 9 × 10 −8 ) was declared after meta‐analyzing the discovery and replication samples. Additional assessment was performed using nasal tissue DNAm data from 155 Spanish individuals. The effects of genetic variation on DNAm were assessed through cis‐methylation quantitative trait loci (meQTL) analysis. Enrichment analyses of previous EWAS signals were conducted. Results: Four CpGs were associated with AEs, and two were replicated and reached genomic significance in the meta‐analysis (annotated to ZBTB16 and BAIAP2 ). Of those, CpG cg25345365 ( ZBTB16 ) was cross‐tissue validated in nasal epithelium ( p = 0.003) and associated with five independent meQTLs (FDR < 0.05). Additionally, four differentially methylated regions and one module were significantly associated with AEs. Enrichment analyses revealed an overrepresentation of prior epigenetic associations with prenatal and environmental exposures, immune‐mediated diseases, and mortality. Conclusions: DNAm in whole blood and nasal samples may contribute to AEs in Europeans, capturing genetic and environmental risk factors.

10 May 2025 in Allergy
Verified
Journal Article
Open access
MLMiriam Leskien
Miriam Leskien
ETElisabeth Thiering
Elisabeth Thiering
ZYZhe-Bin Yu
Zhe-Bin Yu
AHAnke Huels
Anke Huels
YYYueli Yao
Yueli Yao
MSMarie Standl
Marie Standl
Background: Few studies showed associations of childhood allergic diseases with epigenetic aging using traditional clocks trained mainly on adults. Tracking DNA methylation variation early in life has suggested poor performance of these clocks in children. Therefore, we aim to elucidate the association between allergic diseases and epigenetic age using a pediatric clock. Methods: We used data from the German LISA birth cohort study at six ( N = 234) and ten ( N = 227) years. DNA methylation was measured in blood using the Infinium Methylation EPIC BeadChip. We calculated epigenetic age using the pediatric clock developed by Wu et al. (Aging 2019) (median absolute error = 0.04 years, Spearman correlation with chronological age r = 0.75). Linear mixed models were used to examine longitudinal associations of epigenetic age acceleration with doctor‐diagnosed asthma, rhinitis, and eczema, or a combination thereof (“any allergy”) as well as aeroallergen sensitization. Replication was performed in BAMSE at the 8‐year follow‐up ( N = 625) using linear models. Additionally, epigenetic age in adults from KORA F4 was estimated using Horvath's clocks and associations with allergic diseases were tested applying linear models. Results: Having any allergy was significantly associated with a mean epigenetic age acceleration of 0.34 years (95% CI = [0.06; 0.63]) using Wu's clock in LISA. Associations with consistent effect directions were found for allergic rhinitis, asthma, and eczema. No associations with aeroallergen sensitization were observed. In BAMSE, an inverse association of epigenetic age acceleration with eczema was found (−0.52 years, 95% CI = [−0.97; −0.07]). In KORA, hay fever was significantly associated with accelerated epigenetic age when using the Horvath pan‐tissue clock (1.05 years, 95% CI = [0.21; 1.89]). Conclusions: We found an increase in epigenetic age in children with allergic diseases from LISA. Our results suggest that epigenetic age acceleration seems to be related to the persistent burden of allergic diseases, but not to non‐symptomatic aeroallergen sensitization.